Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | SDF1-a | 21.5 | 54 | ||||||||
0 | SDF1-a | 10.5 | 26 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 1 | SDF1-a | 75.0 | 57 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 69.0 | 72 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 65.0 | 55 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 63.0 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 81.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 42.0 | 51 | |
RA2159 | EO1428 | 1.0 | uM | 1 | SDF1-a | 33.0 | 68 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | SDF1-a | 150.0 | 46 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 149.5 | 44 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 120.0 | 41 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 177.0 | 69 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 159.0 | 59 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | SDF1-a | 146.5 | 50 | |
N2586 | EO1428 | 1.0 | uM | 1 | SDF1-a | 54.0 | 62 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | SDF1-a | 104.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | SDF1-a | 99.0 | 72 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SDF1-a | 89.0 | 43 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SDF1-a | 87.0 | 54 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | SDF1-a | 91.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | SDF1-a | 36.5 | 60 | |
RA2159 | PI103 | 0.1 | uM | 1 | SDF1-a | 29.0 | 44 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | SDF1-a | 127.0 | 48 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | SDF1-a | 163.5 | 74 |